Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Moderna Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Accounts payable	487)	302)	18)	7)	31)
Manufacturing	400)	227)	53)	6)	—)
Clinical trials	319)	283)	97)	6)	—)
Raw materials	316)	260)	78)	—)	—)
Loss on future firm purchase commitments	268)	—)	—)	—)	—)
Other external goods and services	264)	79)	92)	21)	22)
Royalties	203)	241)	—)	—)	—)
Compensation-related	190)	126)	95)	27)	23)
Development operations	88)	137)	29)	3)	—)
Other	53)	119)	24)	4)	34)
Accrued liabilities	2,101)	1,472)	470)	68)	79)
Deferred revenue	2,038)	6,253)	3,867)	63)	109)
Income taxes payable	48)	876)	—)	—)	—)
Financing lease liabilities, current	161)	165)	24)	—)	—)
Operating lease liabilities, current	35)	46)	6)	4)	—)
Other	53)	14)	3)	1)	3)
Other current liabilities	249)	225)	34)	5)	3)
Current liabilities	4,923)	9,128)	4,389)	143)	223)
Deferred revenue, non-current	673)	615)	177)	139)	165)
Operating lease liabilities, non-current	92)	106)	97)	94)	—)
Financing lease liabilities, non-current	912)	599)	110)	39)	—)
Deferred lease obligation, non-current	—)	—)	—)	—)	10)
Lease financing obligation	—)	—)	—)	—)	33)
Other non-current liabilities	135)	76)	2)	—)	—)
Non-current liabilities	1,812)	1,396)	387)	271)	209)
Total liabilities	6,735)	10,524)	4,775)	415)	432)
Preferred stock, $0.0001; no shares issued or outstanding	—)	—)	—)	—)	—)
Common stock, par value $0.0001	—)	—)	—)	—)	—)
Additional paid-in capital	1,173)	4,211)	4,802)	2,669)	2,538)
Accumulated other comprehensive income (loss)	(370)	(24)	3)	2)	(1)
Retained earnings (accumulated deficit)	18,320)	9,958)	(2,244)	(1,496)	(1,007)
Stockholders’ equity	19,123)	14,145)	2,561)	1,175)	1,530)
Total liabilities and stockholders’ equity	25,858)	24,669)	7,337)	1,589)	1,962)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Moderna Inc. current liabilities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022 not reaching 2020 level.
Non-current liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Moderna Inc. non-current liabilities increased from 2020 to 2021 and from 2021 to 2022.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Moderna Inc. total liabilities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022 not reaching 2020 level.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Moderna Inc. stockholders’ equity increased from 2020 to 2021 and from 2021 to 2022.

Moderna Inc. (NASDAQ:MRNA)

Balance Sheet: Liabilities and Stockholders’ Equity